After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and… Read More »4 Buy-Rated Blue Chip Stocks With Dividend Hikes Due This Week
A deluge of data for various COVID-19 vaccine candidates is expected in the next month or two, and today’s article notes that strategists at Goldman… Read More »Bracing For COVID Vaccine Results — Encouraging Or Disappointing — In The Coming Weeks
“We do think the coronavirus is most likely a recession-inducing virus, with its own unique characteristics and extra-scary headlines. But despite all the uncertainty and… Read More »The Coronavirus’s Impact On People And Portfolios
In today’s article, the author – who has been investing for 40 years – distills all the knowledge he has acquired over the course of… Read More »3 Strategies To Put You On “A Course To Outperformance”
Be it value, growth, momentum, size, low volatility, some blend thereof – or something else entirely, factor investment strategies have been gaining popularity. In fact,… Read More »“Hooked”: Are Some Investors Addicted To The “Cheap Highs” Of Factor Investment Strategies?
Are you making some serious mistakes – and missing out on opportunities – as an investor as a result of “narrow framing”? The author of… Read More »Are You (And Your Portfolio) The Victims Of “Narrow Framing”?
With the nation’s economic health improving, interest rates on the rise, and the prospect of less regulation under the incoming Trump administration, 2017 appears to… Read More »Financials On Fire: 7 Financial Stocks That Gained More Than 60% In 2016… And Positioned For Further Growth